Conmed (CNMD) Total Current Liabilities (2010 - 2026)

Conmed has reported Total Current Liabilities for 17 years, with the latest figure at $292.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 3.38% year-over-year to $292.7 million; the trailing twelve-month figure through Mar 2026 stood at $292.7 million (up 3.38% YoY), and the FY2025 full-year result was $315.0 million, up 13.27% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $292.7 million, down from $315.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $376.3 million in Q3 2023, with the low at $187.6 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $286.7 million across 5 years, with a median of $292.7 million in 2026.
• Annual changes were most pronounced in 2023 — Total Current Liabilities soared 80.42% — and 2024, when it retreated 24.98%.
• Conmed's Total Current Liabilities stood at $296.6 million in 2022, then gained by 4.78% to $310.7 million in 2023, then declined by 10.49% to $278.1 million in 2024, then advanced by 13.27% to $315.0 million in 2025, then declined by 7.09% to $292.7 million in 2026.
• The last three Total Current Liabilities figures came in at $292.7 million (Q1 2026), $315.0 million (Q4 2025), and $314.7 million (Q3 2025), per Business Quant data.